Xeloda®, Capecitabine is a chemotherapy, one of a group of medications known as “cytostatic medications” that stop the development of cancerous cells.
For adjuvant Colon Cancer: Capecitabine is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes stage C) colon cancer.
Colorectal Cancer: Capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.
Advanced gastric cancer: Capecitabine is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy.
Breast Cancer Combination Therapy: Capecitabine in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.
Breast Cancer Monotherapy: Capecitabine is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.
The medication can be taken by itself or in combination with other medications
